Lumina Fund Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Lumina Fund Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-64,400	Closed	-$3.7M	–	53
2016 Q3	$3.7M	Hold	64,400	–	–	0.4%	16
2016 Q2	$3.77M	Buy	+64,400	New	+$3.75M	0.29%	13

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Lumina Fund Management's PPH Position: Q4 2016 in Review

Lumina Fund Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2016, closing a stake of 64,400 shares — an estimated $3.7M sold.

Lumina Fund Management first reported a position in PPH in Q2 2016 and held it in 2 quarters. The position peaked at $3.77M in Q2 2016. 51 funds tracked by Wall St. Rank hold PPH as of Q4 2016.

Lumina Fund Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2016 after selling out during the quarter.
Lumina Fund Management sold 64,400 VanEck Pharmaceutical ETF shares in Q4 2016, an estimated $3.7M.
Lumina Fund Management first reported a position in VanEck Pharmaceutical ETF in Q2 2016 and held it in 2 quarters.
Lumina Fund Management's VanEck Pharmaceutical ETF position peaked at $3.77M in Q2 2016.
51 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2016.

Based on Lumina Fund Management's 13F filing for Q4 2016, filed 13 Feb 2017.